{"title":"Commentary to Recent advances in the treatment of triple-negative breast cancer","authors":"M. Krzakowski","doi":"10.5603/ocp.2023.0002","DOIUrl":"https://doi.org/10.5603/ocp.2023.0002","url":null,"abstract":"","PeriodicalId":42942,"journal":{"name":"Oncology in Clinical Practice","volume":"3 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82295834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
K. Pogoda, A. Jagiełło-Gruszfeld, M. Kunkiel, A. Niwińska, Z. Nowecki
{"title":"Recent advances in the treatment of triple-negative breast cancer","authors":"K. Pogoda, A. Jagiełło-Gruszfeld, M. Kunkiel, A. Niwińska, Z. Nowecki","doi":"10.5603/ocp.2022.0056","DOIUrl":"https://doi.org/10.5603/ocp.2022.0056","url":null,"abstract":"","PeriodicalId":42942,"journal":{"name":"Oncology in Clinical Practice","volume":"3 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86424230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The current treatment of choice in patients with advanced or metastatic squamous-cell carcinoma (SCC) of the skin is immunotherapy based on anti-PD1/L1 antibodies. For many years, there has been a consensus, that SCC of the skin is a chemorefractory neoplasm. However, despite a recent approval of checkpoint inhibitors for the treatment of cutaneous SCC, their extremely high cost makes them unavailable for many patients worldwide, and additionally, in many patients, their use may be contraindicated by patients’ clinical conditions. This article provides strong arguments that optimized and well-matched chemotherapy still represents an active treatment option even in the era of novel therapies.
{"title":"Strikingly high activity of metronomic chemotherapy in a patient with locally advanced, life-threatening cutaneous squamous-cell cancer — case report and discussion of the literature","authors":"Łukasz Kwinta, P. Wysocki","doi":"10.5603/ocp.2023.0009","DOIUrl":"https://doi.org/10.5603/ocp.2023.0009","url":null,"abstract":"The current treatment of choice in patients with advanced or metastatic squamous-cell carcinoma (SCC) of the skin is immunotherapy based on anti-PD1/L1 antibodies. For many years, there has been a consensus, that SCC of the skin is a chemorefractory neoplasm. However, despite a recent approval of checkpoint inhibitors for the treatment of cutaneous SCC, their extremely high cost makes them unavailable for many patients worldwide, and additionally, in many patients, their use may be contraindicated by patients’ clinical conditions. This article provides strong arguments that optimized and well-matched chemotherapy still represents an active treatment option even in the era of novel therapies.","PeriodicalId":42942,"journal":{"name":"Oncology in Clinical Practice","volume":"34 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87355139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Kahvecioglu, G. Elçin, S. Kılıçkap, O. Gokoz, G. Yazici
{"title":"Adjuvant radiotherapy in the management of porocarcinoma with lymphatic micrometastasis","authors":"A. Kahvecioglu, G. Elçin, S. Kılıçkap, O. Gokoz, G. Yazici","doi":"10.5603/ocp.2023.0003","DOIUrl":"https://doi.org/10.5603/ocp.2023.0003","url":null,"abstract":"","PeriodicalId":42942,"journal":{"name":"Oncology in Clinical Practice","volume":"15 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89525161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Joanna Terebińska, R. Wojciechowski, Filip Zieliński, Anna Skrzypczyk-Ostaszewicz, A. Zegadło, E. Lisiak, Artur Maliborski, R. Duchnowska
{"title":"Management of febrile neutropenia in a breast cancer patient with SARS-CoV-2 infection during dose-dense adjuvant chemotherapy","authors":"Joanna Terebińska, R. Wojciechowski, Filip Zieliński, Anna Skrzypczyk-Ostaszewicz, A. Zegadło, E. Lisiak, Artur Maliborski, R. Duchnowska","doi":"10.5603/ocp.2023.0006","DOIUrl":"https://doi.org/10.5603/ocp.2023.0006","url":null,"abstract":"","PeriodicalId":42942,"journal":{"name":"Oncology in Clinical Practice","volume":"12 3 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78036966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Karol Miklusiak, Agnieszka Łazarczyk, J. Szpor, Ł. Chmura, P. Potocki
{"title":"Challenges in the diagnosis and treatment of peritoneal mesothelioma: a case study and review of the literature","authors":"Karol Miklusiak, Agnieszka Łazarczyk, J. Szpor, Ł. Chmura, P. Potocki","doi":"10.5603/ocp.2023.0005","DOIUrl":"https://doi.org/10.5603/ocp.2023.0005","url":null,"abstract":"","PeriodicalId":42942,"journal":{"name":"Oncology in Clinical Practice","volume":"54 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74129718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Survival of pancreatic cancer patients treated with nab-paclitaxel (nab-P) in clinical practice: Analysis of National Health Fund data","authors":"Ireneusz Raczyński, B. Radecka, M. Krzakowski","doi":"10.5603/ocp.2022.0055","DOIUrl":"https://doi.org/10.5603/ocp.2022.0055","url":null,"abstract":"","PeriodicalId":42942,"journal":{"name":"Oncology in Clinical Practice","volume":"18 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85150510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Mądro, Weronika Kazimierak, A. Grenda, P. Krawczyk
{"title":"Circulating microRNAs as a potential diagnostic marker in chronic pancreatitis, pancreatic cancer and colorectal cancer","authors":"A. Mądro, Weronika Kazimierak, A. Grenda, P. Krawczyk","doi":"10.5603/ocp.2022.0053","DOIUrl":"https://doi.org/10.5603/ocp.2022.0053","url":null,"abstract":"","PeriodicalId":42942,"journal":{"name":"Oncology in Clinical Practice","volume":"12 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77833823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Koçak, M. Çakır, U. Kerimoglu, M. Araz, M. Karakurt Eryılmaz, P. Yumuk, M. Artaç
{"title":"A case of pathologic complete response after neoadjuvant triplet chemotherapy for locally advanced colon cancer with mismatch repair enzyme proficiency","authors":"M. Koçak, M. Çakır, U. Kerimoglu, M. Araz, M. Karakurt Eryılmaz, P. Yumuk, M. Artaç","doi":"10.5603/ocp.2023.0004","DOIUrl":"https://doi.org/10.5603/ocp.2023.0004","url":null,"abstract":"","PeriodicalId":42942,"journal":{"name":"Oncology in Clinical Practice","volume":"10 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90204216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Łomiak, T. Świtaj, M. Spałek, Joanna Radzikowska, M. Chojnacka, S. Falkowski, M. Wągrodzki, W. Kukwa, A. Szumera-Ciećkiewicz, P. Rutkowski, A. Czarnecka
{"title":"Diagnosis and treatment of rhabdomyosarcomas","authors":"M. Łomiak, T. Świtaj, M. Spałek, Joanna Radzikowska, M. Chojnacka, S. Falkowski, M. Wągrodzki, W. Kukwa, A. Szumera-Ciećkiewicz, P. Rutkowski, A. Czarnecka","doi":"10.5603/ocp.2022.0034","DOIUrl":"https://doi.org/10.5603/ocp.2022.0034","url":null,"abstract":"","PeriodicalId":42942,"journal":{"name":"Oncology in Clinical Practice","volume":"34 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78068011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：